JPRN-UMIN000030091招募中未知
Parallel competitive study in two groups to examine the effects of Kampo Medicines (oren-to) for oral mucositis in patients receiving radiation therapy - Effects of Kampo Medicines (oren-to) for oral mucositis in patients receiving radiation therapy
Department of Japanese-Oriental (Kampo) Medicine,Graduate School of Medicine, Chiba University0 个研究点目标入组 30 人开始时间: 2017年11月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient who cannot take Kampo medications at start of this research 2. Patient with allergy for oren-to 3. Patient who is judged to be inappropriate to carry out the research safely by the principal or sub investigator
研究者
相似试验
招募中
4 期
Effects of Kampo Medicines (oren-to) for oral mucositis in patients receiving radiation therapyJPRN-jRCT1031190210amiki Takao30
进行中（未招募）
1 期
Estudio de no inferioridad, en grupos paralelos, multicéntrico, aleatorizado y abierto de las inyecciones subcutáneas de RO0503821 administradas una vez al mes comparado con darbepoetin alfa administrado de acuerdo con la información declarada en la ficha técnica del producto en pacientes con nefropatía crónica que no están en diálisis. - STELLATAefropatía crónicaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemiaEUCTR2006-004552-21-ESF. Hoffmann-La Roche Ltd200
进行中（未招募）
1 期
A phase-II academic trial testing, in two parallel non-randomized cohorts, the combination of ruxolitinib (JAK1/2 inhibitor) with brentuximab or nivolumab in relapsed or refractory classical Hodgkin lymphoma (cHL)Patients with relapsed or refractory cHL that has not responded to, or has progressed after, the previous treatmentMedDRA version: 20.0Level: LLTClassification code 10020328Term: Hodgkin's lymphomaSystem Organ Class: 100000004864EUCTR2019-003084-21-ITPROF.BRUNANGELO FALINI, DR.ENRICO TIACCI. DIPARTIMENTO DI MEDICINA, UNIVERSITA' DI PERUGIA27
已完成
不适用
Two-group, parallel, double-blind study to evaluate the effects of limonite intake on glucose metabolism during 12 weeks.Healthy person (high fasting blood glucose level, up to 125 mg / dl)JPRN-UMIN000039470Mie University, Graduate School of Medicine50
尚未招募
3 期
The Combination of Tirzepatide and Resistance EXercise (T-REX) for the Management of Body CompositioObesityACTRN12623001236684The University of Western Australia120